Vasoplegic syndrome after cardiopulmonary bypass in cardiovascular surgery: Pathophysiology and management in critical care

Z Ltaief, N Ben-Hamouda, V Rancati, Z Gunga… - Journal of Clinical …, 2022 - mdpi.com
Vasoplegic syndrome (VS) is a common complication following cardiovascular surgery with
cardiopulmonary bypass (CPB), and its incidence varies from 5 to 44%. It is defined as a …

[HTML][HTML] The effect of CytoSorb on inflammatory markers in critically ill patients: a systematic review and meta-analysis of randomized controlled trials

M Heymann, R Schorer, A Putzu - Critical Care Medicine, 2023 - journals.lww.com
OBJECTIVES: The effectiveness of CytoSorb at removing inflammatory mediators in critically
ill patients is controversial. DATA SOURCES: Electronic databases were searched from …

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics

VP Chavda, N Raval, S Sheta, LK Vora… - Frontiers in …, 2023 - frontiersin.org
The newly emerged coronavirus (SARS-CoV-2) is virulent, contagious, and has rapidly
gained many mutations, which makes it highly infectious and swiftly transmissible around …

Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states

AJ Westover, HD Humes, CJ Pino - Scientific Reports, 2024 - nature.com
Cell directed therapy is an evolving therapeutic approach to treat organ dysfunction arising
from hyperinflammation and cytokine storm by processing immune cells in an extracorporeal …

Hemadsorption in patients requiring V‐A ECMO support: Comparison of Cytosorb versus Jafron HA330

T Lesbekov, Z Nurmykhametova, R Kaliyev… - Artificial …, 2023 - Wiley Online Library
Background ECMO support is associated with the development of a systemic hyper‐
inflammatory response, which may become quite significant and extreme in some cases. We …

The role of hemoadsorption in cardiac surgery–a systematic review

M Matejic-Spasic, S Lindstedt, G Lebreton… - BMC Cardiovascular …, 2024 - Springer
Background Extracorporeal blood purification has been widely used in intensive care
medicine, nephrology, toxicology, and other fields. During the last decade, with the …

Cytokine hemoadsorption with CytoSorb® in patients with sepsis: A systematic review and meta-analysis

JJC Saldaña-Gastulo, MR Llamas-Barbarán… - Critical Care …, 2023 - SciELO Brasil
Objective: To analyze the effect of CytoSorb® on mortality, interleukin levels, vasopressor
use and adverse events in patients with sepsis. Methods: We searched MEDLINE®, Embase …

[HTML][HTML] Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment

JH Jang, E Choi, T Kim, HJ Yeo, D Jeon… - … Journal of Molecular …, 2024 - ncbi.nlm.nih.gov
Sepsis poses a significant threat to human health due to its high morbidity and mortality
rates worldwide. Traditional diagnostic methods for identifying sepsis or its causative …

[HTML][HTML] Extracorporeal organ support for critically ill patients: Overcoming the past, achieving the maximum at present, and redefining the future

P Papamichalis, KG Oikonomou… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Extracorporeal organ support (ECOS) has made remarkable progress over the last few
years. Renal replacement therapy, introduced a few decades ago, was the first available …

The potential role of extracorporeal cytokine removal with CytoSorb® as an adjuvant therapy in Acute Respiratory Distress Syndrome

D Tomescu, M Popescu, A Akil… - … Journal of Artificial …, 2023 - journals.sagepub.com
Management of acute respiratory distress syndrome (ARDS) represents one of the greatest
challenges in intensive care and despite all efforts mortality remains high. One common …